EUVIMEDEUVIMED entdecken
Crossref

NCI Will Study Drug Combinations in New Precision Treatment Initiative

Emily Harris

JAMA · 2023

DOI: 10.1001/jama.2023.10397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Precision Medicine, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineAntineoplastic AgentsNeoplasmsMolecular Targeted TherapyNational Cancer Institute (U.S.)United StatesDrug Therapy, CombinationClinical Studies as Topic

Substanzen

Antineoplastic Agents

Zitieren

APA

Harris, E. (2023). NCI Will Study Drug Combinations in New Precision Treatment Initiative. JAMA. https://doi.org/10.1001/jama.2023.10397

Vancouver

Harris E. NCI Will Study Drug Combinations in New Precision Treatment Initiative. JAMA. 2023. doi:10.1001/jama.2023.10397

BibTeX
@article{Harris2023,
  author = {Harris, Emily},
  title = {NCI Will Study Drug Combinations in New Precision Treatment Initiative},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.10397}
}
Kostenlos starten →